Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition

Translational Research

Volumn 161, Issue 5, 2013, Pages 414-420

  Badr Eslam, Roza ^a   Lang, Irene M ^a   Kaider, Alexandra ^a   Panzer, Simon ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PADGEM PROTEIN; PRASUGREL; PROTEINASE ACTIVATED RECEPTOR 1; PURINERGIC P2Y12 RECEPTOR; THROMBIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION;

EID: 84876354411     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.12.009     Document Type: Article

References (26)

1. J.L. Anderson, C.D. Adams, and E.M. Antman 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e426 e579
2. D.A. Morrow, E. Braunwald, and M.P. Bonaca Vorapaxar in the secondary prevention of atherothrombotic events N Engl J Med 366 2012 1404 1413
3. M.L. Kahn, M. Nakanishi-Matsui, M.J. Shapiro, H. Ishihara, and S.R. Coughlin Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 1999 879 887
4. G. Soslau, R. Class, D.A. Morgan, C. Foster, S.T. Lord, and P. Marchese Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib J Biol Chem 276 2001 21173 21183
5. K. Jurk, U.R. Jahn, and H. Van Aken Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1) Thromb Haemost 91 2004 334 344
6. A.J. Leger, L. Covic, and A. Kuliopulos Protease-activated receptors in cardiovascular diseases Circulation 114 2006 1070 1077
7. D. Dormann, K.J. Clemetson, and B.E. Kehrel The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity Blood 96 2000 2469 2478
8. F. Adam, M.C. Guillin, and M. Jandrot-Perrus Glycoprotein Ib-mediated platelet activation. A signaling pathway triggered by thrombin Eur J Biochem 270 2003 2959 2970
9. M. Cattaneo Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection J Thromb Haemost 5 Suppl 1 2007 230 237
10. Y. Yano, T. Ohmori, and S. Hoshide Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad Eur Heart J 29 2008 1729 1738
11. J.A. Jakubowski, C.D. Payne, and G.J. Weerakkody Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects J Cardiovasc Pharmacol 49 2007 167 173
12. T. Gremmel, A. Calatzis, and S. Steiner Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel? Platelets 21 2010 515 521
13. V.L. Serebruany, A.I. Malinin, and D.C. Sane Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial Eur J Pharmacol 499 2004 315 324
14. V.L. Serebruany, M. Miller, and A.N. Pokov Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study) Am J Cardiol 97 2006 1332 1336
15. R.B. Eslam, N. Reiter, and A. Kaider Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin Eur Heart J 30 2009 1831 1836
16. D. Sibbing, S. Braun, and T. Morath Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
17. L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
18. V.L. Serebruany, M.G. Midei, and H. Meilman Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study Postgrad Med J 82 2006 404 410
19. J.W. Eikelboom, J.I. Weitz, and A. Budaj Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes Eur Heart J 23 2002 1771 1779
20. F.A. Ofosu, L. Dewar, and S.J. Craven Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin J Biol Chem 283 2008 26886 26893
21. A.L. Frelinger III, M.I. Furman, and M.D. Linden Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896
22. D. Sibbing, T. Morath, and S. Braun Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting Thromb Haemost 103 2010 151 159
23. T. Gremmel, and S. Panzer Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrel Thromb Haemost 106 2011 211 218
24. A.D. Michelson, and M.I. Furman Laboratory markers of platelet activation and their clinical significance Curr Opin Hematol 6 1999 342 348
25. K. Stellos, B. Bigalke, D. Stakos, N. Henkelmann, and M. Gawaz Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication J Thromb Haemost 8 2010 205 207
26. R. Badr Eslam, I.M. Lang, R. Koppensteiner, A. Calatzis, S. Panzer, and T. Gremmel Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitors Int J Cardiol 2012 pii: S0167-5273(12)01209-0. http://dx.doi.org/10.1016/j.ijcard.2012.09.103. (in press)